MRD signifies remaining cancer cells post-treatment, with interpretations varying by cancer type. MRD testing methods include flow cytometry and genomic tests, detecting residual cancer cells.

AUSTIN, Texas, January 15, 2025--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at the 43rd ...

the FN Reflex ® XL MRD. Featuring a slightly longer barrel, an extended grip and compatibility with preferred red dot optics, the FN Reflex XL lets users maximize accuracy while still providing ...

Also in 2024, research using minimal residual disease (MRD) to monitor patients for relapse in drug trials took off, and pharmaceutical companies will continue to use the biomarker in their drug ...